PRICE T ROWE ASSOCIATES INC /MD/
Position in RCKT — Rocket Pharmaceuticals, Inc.
CIK 80255
BALTIMORE, MD
Position in RCKT
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$3,078,348
-$238,155 QoQ
Shares Held
859,874
-9.0% QoQ
Ownership
0.787%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RCKT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $14,300,473,279 across 256 Biotechnology names. RCKT ranks #130 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
3,374,955 | $2,464,560,888 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,177,527 | $1,682,444,460 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,760,122 | $785,964,877 | |
| 4 | INSM |
INSMED Inc
|
3,092,807 | $505,735,799 | |
| 5 | KYMR |
Kymera Therapeutics, Inc.
|
6,060,847 | $504,807,946 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,432,748 | $474,053,330 | |
| 7 | ASND |
Ascendis Pharma A/S
|
1,530,345 | $350,035,811 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
3,232,213 | $314,332,713 |
All Filings in RCKT
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,078,348 | 859,874 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $3,316,503 | 944,873 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $3,459,821 | 1,061,295 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $2,694,581 | 1,099,829 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $20,301,358 | 3,043,682 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $39,576,896 | 3,148,520 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $59,247,714 | 3,207,781 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $68,238,214 | 3,169,448 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $79,288,729 | 2,943,160 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $78,793,347 | 2,629,074 | Shares | Sole | 2024-02-16 | |
| 2023-09-30 | $54,051,615 | 2,637,951 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $42,100,675 | 2,118,806 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $31,981,401 | 1,866,982 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $36,914,694 | 1,886,290 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $26,168,701 | 1,639,643 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $19,365,122 | 1,407,349 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $39,687,841 | 2,502,386 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $47,870,876 | 2,192,894 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $86,215,493 | 2,884,426 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $148,490,418 | 3,352,685 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $159,680,308 | 3,598,835 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $190,805,963 | 3,479,321 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $53,932,820 | 2,359,266 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $29,510,190 | 1,409,947 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $21,312,224 | 1,527,758 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||